Deutsche Bank Ag\ Cellectis S.A. Transaction History

Deutsche Bank Ag\

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$8.01 - $12.84 $26,433 - $42,372	-3,300 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$11.94 - $16.09 $39,402 - $53,097	3,300 New	3,300 $42,000
Q4 2019 Feb 14, 2020	SELL	$9.73 - $19.31 $23,079 - $45,803	-2,372 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$10.15 - $16.89 $1.19 Million - $1.98 Million	-117,145 Reduced 98.02%	2,372 $24,000
Q2 2019 Aug 14, 2019	BUY	$14.6 - $20.6 $760,952 - $1.07 Million	52,120 Added 77.33%	119,517 $1.86 Million
Q1 2019 May 15, 2019	BUY	$15.53 - $19.75 $305,894 - $389,015	19,697 Added 41.29%	67,397 $1.23 Million
Q4 2018 Feb 14, 2019	BUY	$15.58 - $28.41 $440,508 - $803,264	28,274 Added 145.55%	47,700 $794,000
Q3 2018 Dec 21, 2021	BUY	$25.99 - $30.6 $60,166 - $70,839	2,315 Added 13.53%	19,426 $548,000
Q3 2018 Nov 14, 2018	BUY	$25.99 - $30.6 $366,069 - $431,001	14,085 Added 465.47%	17,111 $482,000
Q2 2018 Apr 21, 2020	BUY	$27.78 - $38.53 $39,003 - $54,096	1,404 Added 86.56%	3,026 $86,000
Q2 2018 Aug 14, 2018	SELL	$27.78 - $38.53 $388,669 - $539,073	-13,991 Reduced 89.61%	1,622 $45,000
Q1 2018 Oct 18, 2019	BUY	$27.78 - $35.19 $33,419 - $42,333	1,203 Added 8.35%	15,613 $491,000
Q1 2018 May 15, 2018	BUY	$27.78 - $35.19 $372,640 - $472,038	13,414 Added 1346.79%	14,410 $453,000
Q4 2017 Feb 14, 2018	SELL	$23.33 - $35.01 $1.61 Million - $2.42 Million	-69,204 Reduced 98.58%	996 $29,000
Q3 2017 Nov 14, 2017	BUY	$21.65 - $32.18 $1.52 Million - $2.26 Million	70,200	70,200 $2 Million

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $86M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.